U.S. doctors online nowAsk doctors free
KY
A 50-year-old female asked:

Endometrial biopsy 3/3/15 results - tubal metaplasia and scant sample, so d&c hysteropscopy 04/14/15 results show no tubal metaplasia can it reverse?

2 doctor answers • 2 doctors weighed in
Dr. Gurmukh Singh
Dr. Gurmukh Singhanswered
Pathology 51 years experience
Can: Metaplasia is reversible by definition. However it is more likely that the scant sample on biopsy was insufficient for a definitive diagnosis.
Created for people with ongoing healthcare needs but benefits everyone.
Learn how we can help
2.9k viewsAnswered >2 years ago
Thank
Dr. Marilda Chung
Dr. Marilda Chunganswered
Pathology 38 years experience
Insignificant find: Tubal metaplasia is an insignificant finding in endometrial tissue. Often it is not even mentioned because it is common. It has no association with hyperplasia or cancer at all. It is an incidental finding that is usually present only focally. Your MD undoubtedly repeated the biopsy because the initial biopsy was scant and s/he wanted a better sample, NOT to see if there is more metaplasia.
Created for people with ongoing healthcare needs but benefits everyone.
Learn how we can help
2.8k viewsAnswered >2 years ago
Thank

Related questions

A 61-year-old female asked:
Endometrial biopsy done because uterine lining 9mm thick. Benign, but Dr only able to get scant tissue sample. Why would that happen?
1 doctor answer • 1 doctor weighed in
A 61-year-old female asked:
Endometrial biopsy 9mm w/scant tissue sample no atypical cells but Dr. wants 2nd biopsy. Wasn't enough tissue to make definite diagnosis? Concerning?
1 doctor answer • 2 doctors weighed in
A 61-year-old female asked:
Dr could only get scant sample of endometrial lining for biopsy. Had problem getting through cervix because curved. Extremely painful. Is this common?
1 doctor answer • 1 doctor weighed in
A female asked:
My endometrial biopsy results: Abundant mucus with rare strips of endometrial glands. Scant benign endocervical epithelium. Is this good or bad?
1 doctor answer • 1 doctor weighed in
A 43-year-old female asked:
I had a endometrial biopsy for thickening of the lining of my uterus. The results say this focal atypical complex hyperplasia suspicious for adenocarcinoma. I did another biopsy waiting on results because sample was small. What does this mean?
1 doctor answer • 1 doctor weighed in
Last updated Aug 17, 2015

Found in:

Female health›Biopsy

People also asked

Endometrial biopsy showed "fragments of endocervical mucosa with focal tubal and squamous metaplasia and reactive changes." Should I be worried?
1 doctor answer • 1 doctor weighed in
What does this mean?Endometrial biopsy:benign proliferative endometrium with ciliated cell metaplasia without hyperplasia or malignancy
2 doctor answers • 9 doctors weighed in
What does it mean? Inactive endometrium with focal tubal metaplasia? Benign endometrial polyp.
1 doctor answer • 1 doctor weighed in
What do these endometrial biopsy results mean:DIAGNOSIS: ENDOMETRIUM, BIOPSY - SCANT STRIPS OF INACTIVE GLANDULAR EPITHELIUM ADMIXED WITH INFLAMED MUCUS, KERATIN DEBRIS AND BLOOD. Comment: Sections show rare strips of inactive glandular epithelium?
2 doctor answers • 2 doctors weighed in
Thickened lining, Endometrial biopsy was benign but scant tissue sample. Dr says repeat biopsy in 30 days or do D & C & hysterscopy. How do I decide?
1 doctor answer • 1 doctor weighed in
Connect with a U.S. board-certified doctor by text or video anytime, anywhere.
Talk to a doctor now
24/7 visits - just $44!
50% off with $19/month membership

Disclaimer:

Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.

Get the Free App for Members

Get the Free App for Doctors

HIPAASecure
SOC 2 Type 2Certified
TermsPrivacyCookiesDMCA
Copyright 2023 HealthTap, Inc.